TCM

Tang Capital Management Portfolio holdings

AUM $1.98B
1-Year Return 21.62%
This Quarter Return
-0.55%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.51B
AUM Growth
+$111M
Cap. Flow
+$219M
Cap. Flow %
14.5%
Top 10 Hldgs %
37.54%
Holding
194
New
40
Increased
63
Reduced
17
Closed
11

Sector Composition

1 Healthcare 94.65%
2 Technology 1.65%
3 Communication Services 1.35%
4 Consumer Discretionary 0.56%
5 Financials 0.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ATHA icon
176
Athira Pharma
ATHA
$15.3M
$352K 0.02%
600,000
OTLK icon
177
Outlook Therapeutics
OTLK
$39.5M
$345K 0.02%
182,502
-1,377,058
-88% -$2.6M
RVPH icon
178
Reviva Pharmaceuticals
RVPH
$30.4M
$308K 0.02%
+170,000
New +$308K
KLRS
179
Kalaris Therapeutics, Inc. Common Stock
KLRS
$87.2M
$232K 0.02%
+24,011
New +$232K
AFMD
180
DELISTED
Affimed
AFMD
$176K 0.01%
148,315
IVVD icon
181
Invivyd
IVVD
$209M
$146K 0.01%
330,172
RLMD icon
182
Relmada Therapeutics
RLMD
$45.5M
$104K 0.01%
200,825
+150,000
+295% +$78K
IMRX icon
183
Immuneering
IMRX
$233M
$26.6K ﹤0.01%
+12,073
New +$26.6K
ARVN icon
184
Arvinas
ARVN
$559M
-180,000
Closed -$4.43M
CNTA
185
Centessa Pharmaceuticals
CNTA
$2.12B
-400,000
Closed -$6.4M
GPCR icon
186
Structure Therapeutics
GPCR
$1.14B
-144,500
Closed -$6.34M
IMNM icon
187
Immunome
IMNM
$853M
-720,000
Closed -$10.5M
LVTX icon
188
LAVA Therapeutics
LVTX
$40.8M
-53,101
Closed -$88.1K
MCRB icon
189
Seres Therapeutics
MCRB
$165M
-10,000
Closed -$189K
PCRX icon
190
Pacira BioSciences
PCRX
$1.2B
-61,226
Closed -$921K
PGEN icon
191
Precigen
PGEN
$1.36B
-500,000
Closed -$474K
TYRA icon
192
Tyra Biosciences
TYRA
$647M
-150,000
Closed -$3.53M
RVNC
193
DELISTED
Revance Therapeutics, Inc.
RVNC
-2,500,000
Closed -$13M
EGRX
194
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-118,857
Closed -$443K